Clinical Trial Update: Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining erythropoietin to enhance recovery of erectile function after radical prostatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Prostate Cancer

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Prostate Cancer, Erectile Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2020-08-13